Renvela, containing sevelamer carbonate, lowers phosphate levels in the blood by binding to it in the gastrointestinal tract, preventing its absorption. This is particularly useful for patients with chronic kidney disease (CKD) on dialysis.
Dosage varies significantly depending on individual phosphate levels and response to treatment. A physician determines the starting dose, typically adjusting it based on regular blood tests. Common starting doses range from 800mg to 1600mg three times daily, usually with meals. Always follow your doctor’s prescribed dosage and schedule.
Side effects are generally mild but can include constipation, nausea, vomiting, and abdominal pain. Increased fluid intake and high-fiber diet can help mitigate constipation. Severe side effects are rare but require immediate medical attention. These could include allergic reactions (rash, swelling, difficulty breathing), severe gastrointestinal problems, and significant changes in blood potassium levels. Report any unusual symptoms to your healthcare provider immediately.
Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist for personalized advice regarding Renvela or any medication.
